The DOI matches its Crossref record.
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow‐up study on methods
Abstract
Summary: Background Familial hypocalciuric hypercalcaemia (FHH) must be differentiated from primary hyperparathyroidism (PHPT) because prognosis and treatment differ. In daily practice this discrimination is often based on the renal calcium excretion or the calcium/creatinine clearance ratio (CCCR). However, the diagnostic performance of these variables is poorly documented. Aim To appraise the power of various simple biochemical variables to differentiate between FHH and PHPT using calcium sensing receptor (CASR) gene analysis and histopathological findings as gold standards. Design Follow‐up approach (direct design). Materials We included 54 FHH patients (17 males and 37 females, aged 18–75 years) with clinically significant mutations in the CASR gene and 97 hypercalcaemic patients with histologically verified PHPT (17 males and 80 females, aged 19–86 years). All PHPT patients became normocalcaemic following successful neck exploration. Results Based on receiver operating characteristic (ROC) curve analysis, the CCCR was only marginally better, as judged by the area under curve (AUC = 0·923 ± 0·021 (SE)), than the 24‐h calcium/creatinine excretion ratio (AUC = 0·903 ± 0·027) and the 24‐h calcium excretion (AUC = 0·876 ± 0·029). However, overlap performance analysis disclosed that the CCCR included fewer patients with PHPT together with the FHH patients than the other two variables at different cut‐off points. Based on the ROC curve, the optimal cut‐off point for diagnosing FHH using CCCR was < 0·0115, which yielded a diagnostic specificity of 0·88 and a sensitivity of 0·80. Overlap analysis revealed that a cut‐off point for CCCR at < 0·020 would sample 98% (53/54) of all patients with FHH and include 35% (34/97) of the PHPT patients. Conclusion Our results support the use of the CCCR as an initial screening test for FHH. We suggest a two‐step diagnostic procedure, where the first step is based on the CCCR with a cut‐off at < 0·020, and the second step is CASR gene analysis in patients with FHH or PHPT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Silverberg, S. J., Lewiecki, E. M., Mosekilde, L., Peacock, M., & Rubin, M. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1760 · Cited by 688
Self-citationThe calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases
Hannan, F. M., Kallay, E., Chang, W., Brandi, M. L., & Thakker, R. V. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0115-0 · Cited by 394
Physiology and pathophysiology of the calcium-sensing receptor in the kidney
Riccardi, D., & Brown, E. M. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00608.2009 · Cited by 359
Hormones and Disorders of Mineral Metabolism
Bringhurst, F. R., Demay, M. B., & Kronenberg, H. M. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00028-6 · Cited by 298
Metadata
- Authors
- Christensen, S. E., Nissen, P. H., Vestergaard, P., Heickendorff, L., Brixen, K., & Mosekilde, L.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2008-10-14
- Volume
- 69
- Issue
- 5
- Pages
- 713-720
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2119753313
- Cited by
- 173
- References
- 0
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow‐up study on methods. https://app.cochat.ai/papers/10.1111/j.1365-2265.2008.03259.x
- The paper
- Christensen, S. E., Nissen, P. H., Vestergaard, P., Heickendorff, L., Brixen, K., & Mosekilde, L. (2008). Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow‐up study on methods. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2008.03259.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.